Skip to content

Clinical trials

Phase 2 Dengue trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dengue Phase: Phase 2 Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20063
20072
20083
20094
20102
20111
20122
20132
20143
20151
20164
20171
20182
20192
20211
20223
20234
20243
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Recruiting4
Terminated3
Unknown status3
Active, not recruiting2
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi Pasteur, a Sanofi Company14
Takeda4
National Institute of Allergy and Infectious Diseases (NIAID)3
Sanofi3
U.S. Army Medical Research and Development Command3
Butantan Institute2
Janssen Research & Development, LLC2
Oxford University Clinical Research Unit, Vietnam2
AbViro LLC1
Atea Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dengue48
Severe Dengue19
Hemorrhagic Fevers, Viral2
Virus Diseases2
Acquired Immunodeficiency Syndrome1
Cytokine Release Syndrome1
Infections1
Macrophage Activation Syndrome1
Vector Borne Diseases1
Yellow Fever1

Trials

Showing 51 to 48 of 48. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.